NICOX (EPA:COX) | Finanzwire

Basculer en Français

10936	Companies
238805	Keywords
167666	Articles
128365	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 09/04/2025 at 07:30, 1 year ago

Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
Nicox expects to fully repay financial debts in 2026 with NCX 470 de-risked and globally licensed, providing a financial update and strategic options. Milestones payable on NDA submissions and approvals

Strategic Options Nicox NCX 470 Financial Debts NDA Submissions
BRIEF

published on 08/26/2025 at 07:35, 1 year ago

Nicox launches FAQ page for shareholders

Shareholders Transparency Ophthalmology Nicox FAQ
PRESS RELEASE

published on 08/26/2025 at 07:30, 1 year ago

Nicox Announces Shareholder Q&A Webpage Available
Nicox introduces Q&A webpage for shareholders on nicox.com, addressing common queries about the company and its operations. Contact communications@nicox.com for investor queries

Shareholders Ophthalmology Nicox Q&A Webpage Investor Questions
BRIEF

published on 08/12/2025 at 15:58, 1 year ago

Soleus Capital Crosses Threshold in NICOX

Voting Rights Actions Threshold Crossing Nicox Soleus Capital
BRIEF

published on 08/08/2025 at 07:35, 1 year ago

Nicox Expands Equity Financing with Vester Finance

Equity Financing Nicox Share Dilution Phase 3 Results Vester Finance
PRESS RELEASE

published on 08/08/2025 at 07:30, 1 year ago

Nicox Extends Existing Flexible Equity Financing
Nicox extends PACEO equity line with Vester Finance by adding 5 million shares. NCX 470 Denali Phase 3 results expected in mid-August to mid-September 2025

Equity Financing Nicox Phase 3 Results NCX 470 Denali Vester Finance
BRIEF

published on 06/30/2025 at 07:35, 1 year 2 months ago

Nicox Achieves Milestone in NCX 470 Phase 3 Clinical Trial

Glaucoma Ocular Hypertension Phase 3 Trial Nicox NCX 470
PRESS RELEASE

published on 06/30/2025 at 07:30, 1 year 2 months ago

Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial
Nicox announces completion of Denali Phase 3 trial for NCX 470 eye drop, expecting results mid-August to mid-September 2025. NDA submission in the U.S. targeted for H1 2026

Phase 3 Trial Ophthalmology Nicox NCX 470 NDA Submission
BRIEF

published on 06/06/2025 at 07:35, 1 year 2 months ago

Nicox Announces Shareholders’ Meeting and Ad Hoc Representative

Voting Rights Shareholders’ Meeting Euronext Growth Nicox Ad Hoc Representative
PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year 2 months ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation

Accesswire

Published on 09/04/2026 at 23:30, 3 hours 15 minutes ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 hours 45 minutes ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 4 hours 15 minutes ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 12 hours 15 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 12 hours 45 minutes ago

Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair

View all ACCESSWIRE

EQS Group

Published on 09/04/2026 at 22:10, 4 hours 35 minutes ago

Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 7 hours 25 minutes ago

Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 18:55, 7 hours 50 minutes ago

Holding(s) in Company
Published on 09/04/2026 at 18:50, 7 hours 55 minutes ago

A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset
Published on 09/04/2026 at 18:05, 8 hours 40 minutes ago

Grundig Unveils New Product Lineup at IFA 2026, Marking a New Phase in Strategic Partnership

Les Echos

Published on 09/04/2026 at 18:57, 7 hours 48 minutes ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 9 hours ago

Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 17:45, 9 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 09/04/2026 at 16:00, 10 hours 45 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 10 hours 45 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE